These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22328398)

  • 1. Mouse intravenous challenge models and applications.
    MacCallum DM
    Methods Mol Biol; 2012; 845():499-509. PubMed ID: 22328398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse model of invasive fungal infection.
    MacCallum DM
    Methods Mol Biol; 2013; 1031():145-53. PubMed ID: 23824897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of candidiasis.
    Clancy CJ; Cheng S; Nguyen MH
    Methods Mol Biol; 2009; 499():65-76. PubMed ID: 19152040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy.
    Jacobsen ID; Lüttich A; Kurzai O; Hube B; Brock M
    J Antimicrob Chemother; 2014 Oct; 69(10):2785-96. PubMed ID: 24951534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
    MacCallum DM; Odds FC
    Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
    J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization and virulence study of ADE8 and GUA1 genes involved in the de novo purine biosynthesis in Candida albicans.
    Jiang L; Zhao J; Guo R; Li J; Yu L; Xu D
    FEMS Yeast Res; 2010 Mar; 10(2):199-208. PubMed ID: 20082641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an extract of North American ginseng (Panax quinquefolius L.) in Candida albicans-infected complement-deficient mice.
    Trammell RA; Cox L; Pikora J; Murphy LL; Toth LA
    J Ethnopharmacol; 2012 Jan; 139(2):414-21. PubMed ID: 22138349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking into Candida albicans infection, host response, and antifungal strategies.
    Wang Y
    Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orogastrointestinal model of mucosal and disseminated candidiasis.
    Clemons KV; Stevens DA
    Methods Mol Biol; 2012; 845():557-67. PubMed ID: 22328404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
    Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
    Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
    Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
    FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans.
    Wanasaengsakul S; Ashman RB
    Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence mechanisms of Candida albicans.
    Cotter G; Kavanagh K
    Br J Biomed Sci; 2000; 57(3):241-9. PubMed ID: 11050778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione.
    Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B
    FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mouse Model of Candidiasis.
    Fajardo P; Cuenda A; Sanz-Ezquerro JJ
    Methods Mol Biol; 2021; 2321():63-74. PubMed ID: 34048008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galleria mellonella as a model for fungal pathogenicity testing.
    Fallon J; Kelly J; Kavanagh K
    Methods Mol Biol; 2012; 845():469-85. PubMed ID: 22328396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.